Danaher (DHR) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)
Danaher (DHR) Net Income towards Common Stockholders Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 8.89% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -7.69% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 15.47% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -6.41% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 14.70% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 2.87% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 16.51% |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | 10.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 26, 2026 | -7.69% |
| Mar 27, 2026 | -10.37% |
| Dec 31, 2025 | -18.80% |
| Sep 26, 2025 | -16.35% |
| Jun 27, 2025 | -30.57% |
| Mar 28, 2025 | -17.26% |
| Dec 31, 2024 | -14.65% |
| Sep 27, 2024 | -9.86% |
| Jun 28, 2024 | -19.58% |
| Mar 29, 2024 | -13.15% |
| Dec 31, 2023 | -3.48% |
| Sep 29, 2023 | 10.27% |
| Jun 30, 2023 | 7.43% |
| Mar 31, 2023 | 35.37% |
| Dec 31, 2022 | 20.74% |
| Sep 30, 2022 | 33.74% |
| Jul 1, 2022 | 32.76% |
| Apr 1, 2022 | 72.64% |
| Dec 31, 2021 | 32.75% |
| Oct 1, 2021 | 18.95% |